[HTML] from nih.govU Emmenegger, G Francia, A Chow… - … (New York, NY), 2011 - ncbi.nlm.nih.gov Low-dose metronomic (LDM) chemotherapy is emerging as an alternative or supplemental dosing strategy to conventional maximum tolerated dose (MTD) chemotherapy. It is characterized primarily, but not exclusively, by antiangiogenic mechanisms of action and the absence of ... Cited by 2 - Related articles - All 4 versions
I Madani, F Duprez, T Boterberg… - Radiotherapy and …, 2011 - Elsevier Adaptive intensity-modulated radiotherapy was based on voxel intensity of pre-treatment and per-treatment [ 18 F]fluoro-2-deoxy-d-glucose positron emission tomography ( 18 F-FDG-PET) scans. Dose was escalated to a median total dose of 80.9 Gy in the ... Related articles - All 2 versions
F Thaler… - Expert Opinion on Drug Discovery, 2011 - informahealthcare.com ... activity and bioavailability compared to SAHA was confirmed also in an in vivo efficacy experiment: HCT-116 tumor-bearing mice were dosed orally with single doses of either 50 or 125 mg/kg of SB939 or 200 mg/kg of SAHA, and at the maximumtolerateddose SB939 was ... Related articles - All 2 versions
[PDF] from uu.nlSLW Koolen, JJ Moes… - … -to-oral switch in …, 2011 - igitur-archive.library.uu.nl ... Study design The study was designed as a two-arm, open-label, non-randomized dose escalation study to define the safety profile, pharmacokinetics and maximumtolerateddose (MTD) of oral docetaxel in a weekly dosing schedule in combination with ritonavir. ... Related articles - View as HTML